Acute Myeloid Leukemia Following Myelodysplastic Syndrome and Failure of Therapy with Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

We assessed outcome of 63 patients with acute myeloid leukemia (AML) arising from myelodysplastic syndrome (MDS) failing hypomethylating agents (HMA). Median age was 63 years. All 63 patients received at least 1 salvage regimen for AML and 35 patients (55%) received 2 or more. Of the 31 patients (49...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Jabbour, Elias, Ghanem, Hady, Huang, Xuelin, Ravandi, Farhad, Garcia-Manero, Guillermo, O’Brien, Susan, Faderl, Stephan, Pierce, Sherry, Choi, Sangbum, Verstovsek, Srdan, Brandt, Mark, Cortes, Jorge, Kantarjian, Hagop
التنسيق: Artigo
اللغة:Inglês
منشور في: 2013
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4098769/
https://ncbi.nlm.nih.gov/pubmed/24447728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2013.10.013
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة